CL2004001132A1 - PROCEDURE FOR PREPARING THE ELITRIPTAN ANHYDR HEMISULFATE POLYMORPH I, USEFUL IN THE TREATMENT OF CONDITIONS FOR WHICH A 5-HT1 RECEIVER AGONIST IS INDICATED, AS MIGRAN. - Google Patents

PROCEDURE FOR PREPARING THE ELITRIPTAN ANHYDR HEMISULFATE POLYMORPH I, USEFUL IN THE TREATMENT OF CONDITIONS FOR WHICH A 5-HT1 RECEIVER AGONIST IS INDICATED, AS MIGRAN.

Info

Publication number
CL2004001132A1
CL2004001132A1 CL200401132A CL2004001132A CL2004001132A1 CL 2004001132 A1 CL2004001132 A1 CL 2004001132A1 CL 200401132 A CL200401132 A CL 200401132A CL 2004001132 A CL2004001132 A CL 2004001132A CL 2004001132 A1 CL2004001132 A1 CL 2004001132A1
Authority
CL
Chile
Prior art keywords
migran
elitriptan
anhydr
hemisulfate
polymorph
Prior art date
Application number
CL200401132A
Other languages
Spanish (es)
Inventor
Aranda-Martinez Catheri Julian
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CL2004001132A1 publication Critical patent/CL2004001132A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
CL200401132A 2003-05-30 2004-05-19 PROCEDURE FOR PREPARING THE ELITRIPTAN ANHYDR HEMISULFATE POLYMORPH I, USEFUL IN THE TREATMENT OF CONDITIONS FOR WHICH A 5-HT1 RECEIVER AGONIST IS INDICATED, AS MIGRAN. CL2004001132A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0312478.1A GB0312478D0 (en) 2003-05-30 2003-05-30 Improved process

Publications (1)

Publication Number Publication Date
CL2004001132A1 true CL2004001132A1 (en) 2005-03-18

Family

ID=9959072

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401132A CL2004001132A1 (en) 2003-05-30 2004-05-19 PROCEDURE FOR PREPARING THE ELITRIPTAN ANHYDR HEMISULFATE POLYMORPH I, USEFUL IN THE TREATMENT OF CONDITIONS FOR WHICH A 5-HT1 RECEIVER AGONIST IS INDICATED, AS MIGRAN.

Country Status (10)

Country Link
EP (1) EP1633739A1 (en)
JP (1) JP2006528968A (en)
AR (1) AR044463A1 (en)
BR (1) BRPI0410841A (en)
CA (1) CA2527127A1 (en)
CL (1) CL2004001132A1 (en)
GB (1) GB0312478D0 (en)
MX (1) MXPA05012838A (en)
TW (1) TWI290923B (en)
WO (1) WO2004106327A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651637B2 (en) * 1990-10-15 1994-07-28 Pfizer Inc. Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
EA002174B1 (en) * 1997-07-03 2002-02-28 Пфайзер Инк. Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt

Also Published As

Publication number Publication date
GB0312478D0 (en) 2003-07-09
TW200427683A (en) 2004-12-16
JP2006528968A (en) 2006-12-28
TWI290923B (en) 2007-12-11
AR044463A1 (en) 2005-09-14
EP1633739A1 (en) 2006-03-15
MXPA05012838A (en) 2006-02-13
WO2004106327A1 (en) 2004-12-09
CA2527127A1 (en) 2004-12-09
BRPI0410841A (en) 2006-06-27

Similar Documents

Publication Publication Date Title
NO20075298L (en) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
WO2007003961A3 (en) Gpcr agonists
AP2414A (en) Fungicidal aqueous compositions for seed treatment.
EA200800549A1 (en) REGIONAL SELECTIVE METHOD FOR OBTAINING BENZIMIDAZOLTHIOPHENES
MX2009007180A (en) Piperidine gpcr agonists.
HK1099019A1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
ITTO20030185A1 (en) IMPROVED STABILIZATION OF OFFSET FOR ECCENTRIC REAMERS.
BRPI0519709A2 (en) tetraline and indane derivatives and their use as 5-ht antagonists
MA28576B1 (en) PROCESS FOR THE PREPARATION OF N-PIPERIDINO-1,5-DIPHENYLPYRAZOLE-3-CARBOXAMIDE DERIVATIVES
ATE458727T1 (en) ARYLSULFONYLBENZODIOXANES SUITABLE FOR MODULATION OF THE 5-HT6 RECEPTOR, THE 5-HT2A RECEPTOR OR BOTH RECEPTORS
NO20052557D0 (en) Morpholine derivatives for use as dopamine agonists in the treatment of, inter alia, sexual dysfunction.
DE502006009099D1 (en) CONSTRUCTION MACHINE, AS WELL AS SWIVELING DEVICE
DK1881830T3 (en) 4-Phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives for the treatment of infertility
ITTV20040005A1 (en) SPORT FOOTWEAR STRUCTURE, ESPECIALLY FOR MOTORCYCLING
CL2004001132A1 (en) PROCEDURE FOR PREPARING THE ELITRIPTAN ANHYDR HEMISULFATE POLYMORPH I, USEFUL IN THE TREATMENT OF CONDITIONS FOR WHICH A 5-HT1 RECEIVER AGONIST IS INDICATED, AS MIGRAN.
CL2007003443A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED BENZOXAZOLES; PREPARATION PROCEDURE, USEFUL AS STROGEN AGENTS.
ES1059187Y (en) ICE CUTTING MACHINE.
CL2007003442A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED BENZOXAZOLES; PREPARATION PROCEDURE, USEFUL AS STROGEN AGENTS.
FR2911490B1 (en) REMOVABLE PHYSIOLOGICAL ORTHOPEDIC GROWTH ACTIVATOR.
FR2867028B1 (en) PROCESS FOR CUTTING EXTRUDATES
ES1058598Y (en) COLLECTION DEVICE FOR THE ESTIBATE OF FISHING NETWORKS.
ITVE20040037A1 (en) PROCESS OF ACETYLENE CYLINDER TREATMENT.
ITRM20060710A1 (en) SUPPORT DEVICE FOR THE CORRECTION OF THE HYPERPHOSUS.
ITTO20040364A1 (en) ORTHESIS BY FOOT.
SE0401146D0 (en) Doctor blade holder